Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International journal of pharmaceutics

• Publication date

  2013-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2013.02.038PMID 23438978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and Toxicokinetics

  2013cited by this paper
• Noncovalent complexation of amphotericin-B with Poly(α-glutamic acid).

  2013cited by this paper
• Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada.

  2012cited by this paper
• [Liposomal amphotericin B: a unique pharmacokinetic profile. An unfinished story].

  2012cited by this paper
• Targeting kidney mesangium by nanoparticles of defined size

  2011cited by this paper
• Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.

  2010cited by this paper
• HPLC assay for determination of amphotericin B in biological samples.

  2008cited by this paper
• Effect of aggregation state on the toxicity of different amphotericin B preparations.

  2008cited by this paper
• In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.

  2008cited by this paper
• Amphotericin B formulations and drug targeting.

  2008cited by this paper
• Clinical pharmacokinetics of systemically administered antimycotics.

  2007cited by this paper
• A physical and chemical stability study of amphotericin B lipid complexes A (ABELCET®) after dilution in dextrose 5%.

  2007cited by this paper
• Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres

  2004cited by this paper
• Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.

  2003cited by this paper
• Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length.

  2003cited by this paper
• A kinetics study of pig erythrocyte hemolysis induced by polyene antibiotics.

  2003cited by this paper
• Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.

  2003cited by this paper
• Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).

  2003cited by this paper
• Heat-induced superaggregation of amphotericin B modifies its interaction with serum proteins and lipoproteins and stimulation of TNF-alpha.

  2001cited by this paper
• Mild Heating of Amphotericin B-Desoxycholate: Effects on Ultrastructure, In Vitro Activity and Toxicity, and Therapeutic Efficacy in Severe Candidiasis in Leukopenic Mice

  2000cited by this paper
• Safety and Toxicokinetics of Intravenous Liposomal Amphotericin B (AmBisome ®) in Beagle Dogs

  1999cited by this paper
• Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients

  1998cited by this paper
• Biomedical applications of nanotechnology--implications for drug targeting and gene therapy.

  1997cited by this paper
• Carrier effects on biological activity of amphotericin B

  1996cited by this paper
• Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting

  1996cited by this paper
• Biodegradable long-circulating polymeric nanospheres.

  1994cited by this paper
• Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs

  1992cited by this paper
• Albumin microspheres. I: Physico-chemical characteristics.

  1989cited by this paper
• Albumin microspheres. II: Applications in drug delivery.

  1989cited by this paper
• Pharmacokinetics of medetomidine.

  1989cited by this paper
• Pharmacokinetics of medetomidine.

  1989cited by this paper
• Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani

  1987cited by this paper
• CORRELATION OF PARTICLE SIZE OF INTRAVENOUS AMPHOTERICIN B WITH TOXIC AND CHEMOTHERAPEUTIC EFFECTS.

  1963cited by this paper
• Drug, Healthcare and Patient Safety Dovepress Safety Aspects and Rational Use of a Naproxen + Esomeprazole Combination in the Treatment of Rheumatoid Disease

  year unknowncited by this paper

• Development of a Turmeric Essential Oil-Based Nanoemulsion for Amphotericin B with Improved Solubility, Sustained Release, and Synergistic Antifungal Efficacy

  2026cites this paper
• Mechanistic Insights from Differences in the Aggregate Morphologies of Amphotericin B and Its Less Toxic Variant Am-2-19 (Turletricin)

  2026cites this paper
• Trimethyl Chitosan-Based Amphotericin B Nanoparticles: Improved Gastrointestinal Stability, Hemocompatibility, Monomeric Stabilization, and Controlled Drug Release

  2025cites this paper
• Transferosomes As A Promising Platform for Targeted Antifungal Drug Delivery

  2025cites this paper
• Antimicrobial 3D printed implants for periprosthetic joint infections.

  2025cites this paper
• Detailed physicochemical characterization of charged and neutral LeciPlex®: loading efficiency and in vitro activity of Voriconazole and Amphotericin B.

  2025cites this paper
• Unraveling the potential of bioadhesive antimicrobial microparticles for the treatment of prosthetic joint infections

  2025cites this paper
• Continuous manufacturing of nanomedicines using 3D-printed microfluidic devices

  2025cites this paper
• Mangifera indica phytochemical enriched ZnO-Amphotericin B Nanoconjugates: Enhanced hydrophilicity, reduced toxicity and pH-sensitive release for targeted anti-Candida therapy

  2025cites this paper
• Quercetin enhances amphotericin B activity and regulates ROS and cytokine production in human monocytes infected by Leishmania infantum.

  2025cites this paper
• Microencapsulation Techniques in HIV Pediatric Formulations: Advances and Future Outlook

  2024cites this paper
• Amphotericin B Ocular Films for Fungal Keratitis and a Novel 3D-Printed Microfluidic Ocular Lens Infection Model

  2024cites this paper
• Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

  2024cites this paper
• Distearoyl phosphatidylglycerol and dioleoyl phosphatidylglycerol increase the retention and reduce the toxicity of amphotericin B loaded in nanoemulsions.

  2024cites this paper
• 3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals

  2023cites this paper
• Can Amphotericin B and Itraconazole be co-delivered orally? Tailoring Oral Fixed-Dose Combination Coated Granules for Systemic Mycoses.

  2023cites this paper
• Incidence of acute kidney injury in dogs with systemic mycotic infections treated with amphotericin B (1996‐2020)

  2023cites this paper
• Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers.

  2023cites this paper
• Effect of Amphotericin B on the thermodynamic stability, aggregation state, hemolysis and antifungal activity of Amphotericin B-nonionic surfactant micellar system

  2023cites this paper
• Exploring temozolomide encapsulated PEGylated Liposomes and Lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies.

  2023cites this paper
• Amphotericin B and monoacyl-phosphatidylcholine form a stable amorphous complex that can facilitate oral administration of amphotericin B.

  2023cites this paper
• Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity

  2022cites this paper
• University of Birmingham Alginate-based microparticles coated with HPMCP/AS cellulose-derivatives enable the Ctx(Ile21)-Ha antimicrobial peptide application as a feed additive

  2022cites this paper
• Conjugation of Ctx(Ile21)-Ha Antimicrobial Peptides to Chitosan Ultrathin Films by N-Acetylcysteine Improves Peptide Physicochemical Properties and Enhances Biological Activity

  2022cites this paper
• Improved In Vitro Anti-Mucorales Activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant

  2022cites this paper
• Nanogels as Antifungal‐Drug Delivery System Against Aspergillus Fumigatus

  2021cites this paper
• Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs

  2021cites this paper
• A review on liposomal amphotericin b in antifungal therapy

  2021cites this paper
• Calendula flower extract loaded PVA hydrogel sheet for wound management: Optimization, characterization and in-vivo study

  2021cites this paper
• Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers.

  2021cites this paper
• Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin

  2021cites this paper
• Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease.

  2021cites this paper
• Alginate-based microparticles coated with HPMCP/AS cellulose-derivatives enable the Ctx(Ile21)-Ha antimicrobial peptide application as a feed additive

  2021cites this paper
• Developing effective amphotericin B delivery systems for fungal infections

  2021cites this paper
• The Use of Phospholipids to Make Pharmaceutical Form Line Extensions

  2021cites this paper
• Alginate-amphotericin B nanocomplexes covered by nanocrystals from bacterial cellulose: physico-chemical characterization and in vitro toxicity

  2021cites this paper
• Microneedle Liquid Injection System Assisted Delivery of Infection Responsive Nanoparticles: A Promising Approach for Enhanced Site-Specific Delivery of Carvacrol against Polymicrobial Biofilms-Infected Wounds.

  2020cites this paper
• In Vitro and In Vivo Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids.

  2020cites this paper
• Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms

  2020cites this paper
• Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.

  2020cites this paper
• Ultra-deformable lipid vesicles localise Amphotericin B in the dermis for the treatment of skin infectious diseases.

  2020cites this paper
• Encapsulating paclitaxel in polymeric nanomicelles increases antitumor activity and prevents peripheral neuropathy.

  2020cites this paper
• Topical Delivery of Amphotericin B Utilizing Transferosomes for the Treatment of Cutaneous Leishmaniasis

  2020cites this paper
• Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models

  2019cites this paper
• Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis

  2019cites this paper
• Preparation, Characterization, and In Vivo Pharmacokinetic Study of the Supercritical Fluid-Processed Liposomal Amphotericin B

  2019cites this paper
• Critical process parameters in manufacturing of liposomal formulations of amphotericin B.

  2019cites this paper
• Pharmacokinetic Profile and Anti-Adhesive Effect of Oxaliplatin-PLGA Microparticle-Loaded Hydrogels in Rats for Colorectal Cancer Treatment

  2019cites this paper
• Designing Fast-Dissolving Orodispersible Films of Amphotericin B for Oropharyngeal Candidiasis

  2019cites this paper
• Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.

  2019cites this paper
• Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis

  2019cites this paper
• A Mechanistic Study to Determine the Structural Similarities Between Artificial Membrane Strat-M™ and Biological Membranes and Its Application to Carry Out Skin Permeation Study of Amphotericin B Nanoformulations

  2018cites this paper
• Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis

  2018cites this paper
• Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis.

  2018cites this paper
• Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B

  2018cites this paper
• Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating

  2018cites this paper
• Comparison of the pharmacokinetic profiles of two different amphotericin B formulations in healthy dogs

  2018cites this paper
• Leishmanicidal candidate LASSBio-1736, a cysteine protease inhibitor with favorable pharmacokinetics: low clearance and good distribution

  2018influential citation
• Oral and Parenteral Amorphous Amphotericin B 1 Formulations against Experimental Trypanosoma cruzi Infections

  2017cites this paper
• Analgesic and anti‐inflammatory controlled‐released injectable microemulsion: Pseudo‐ternary phase diagrams, in vitro, ex vivo and in vivo evaluation

  2017cites this paper
• Oral amphotericin B: The journey from bench to market

  2017cites this paper
• Engineering Synergistically Active and Bioavailable Cost-effective Medicines for Neglected Tropical Diseases; The Role of Excipients.

  2017cites this paper
• Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.

  2017cites this paper
• Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting.

  2017cites this paper
• Safe and Effective Delivery of Amphotericin B: A Survey of Patents.

  2017cites this paper
• Anti-fungal activity of Ctn[15–34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin

  2016cites this paper
• Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis

  2016cites this paper
• Current status on prevention and treatment of canine leishmaniasis.

  2016cites this paper
• Pharmaceutics of Nanoparticles

  2016cites this paper
• Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature

  2015cites this paper
• Recent approaches for reducing hemolytic activity of chemotherapeutic agents.

  2015cites this paper
• Bovine Serum Albumin Nanoparticles Containing Amphotericin B: Characterization, Cytotoxicity and In Vitro Antifungal Evaluation.

  2015cites this paper
• Formulations, Hemolytic and Pharmacokinetic Studies on Saikosaponin a and Saikosaponin d Compound Liposomes

  2015cites this paper
• Chloramphenicol encapsulated in poly-ε-caprolactone–pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds

  2015cites this paper
• Unresponsiveness of Experimental Canine Leishmaniosis to a New Amphotericin B Formulation

  2015cites this paper
• Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.

  2015cites this paper
• Perfil fitoquímico, actividad anti-Leishmania, hemolítica y toxicológica de Cordia dentata Poir. y Heliotropium indicum L.

  2014cites this paper
• Cytarabine-AOT catanionic vesicle-loaded biodegradable thermosensitive hydrogel as an efficient cytarabine delivery system.

  2014cites this paper
• Phytochemical profile and antileishmanial, hemolytic and toxicological activity of Cordia dentata Poir and Heliotropium indicum L.

  2014cites this paper
• Hyaluronic acid-quercetin conjugate micelles: synthesis, characterization, in vitro and in vivo evaluation.

  2014cites this paper
• Study of amphotericin B magnetic liposomes for brain targeting.

  2014cites this paper
• AVALIAÇÃO DA ATIVIDADE ANTILEISHMANIAL IN VITRO E IN VIVO DE UM DERIVADO DE CLOROQUINOLINA CONTRA ESPÉCIES DE LEISHMANIA CAPAZES DE CAUSAR LEISHMANIOSE

  year unknowncites this paper